首頁 > 市場調查報告書 > 醫療設備

傷口護理

市場調查報告書

商品編碼

1724175

傷口清洗劑市場 - 全球及區域分析：按產品類型、按傷口、按最終用戶、按國家/地區 - 分析與預測（2025-2035 年）

Wound Cleanser Market - A Global and Regional Analysis: Focus on Product, Wound Type, End User, and Country Analysis - Analysis and Forecast, 2025-2035

出版日期: 2025年05月14日 | 出版商:

BIS Research | 英文 110 Pages | 商品交期: 1-5個工作天內

價格

簡介目錄圖表

由於對有效創傷護理解決方案的需求不斷增加，傷口清洗市場成為醫療保健行業中一個快速成長的領域。

傷口清洗是清洗和沖洗傷口的專用溶液，在創傷護理管理中發揮重要作用。傷口清洗市場包括各種各樣的產品，旨在去除傷口中的殘留物、細菌和污染物，以確保最佳癒合和預防感染。這些產品對於傷口後續治療的準備至關重要，例如敷料、縫合和其他治療性介入，這使得傷口清洗市場成為現代醫療保健的重要組成部分。

有幾個因素推動了傷口清洗市場的擴張，包括慢性病盛行率的上升，這導致對創傷護理產品的需求增加。外科手術和創傷病例的增加進一步增加了對傷口清洗解決方案的需求，促進了整個傷口清洗市場的成長。此外，傷口感染疾病的增加凸顯了有效傷口清洗的重要性，推動了傷口清洗劑市場的創新和進步。

促進傷口清洗市場擴張的另一個關鍵因素是先進創傷護理產品的接受度和採用率不斷提高。專門創傷護理診所的興起和醫療技術的進步使得人們在臨床和居家照護中對傷口清洗劑的認知和使用率有所提高。傷口清洗市場不斷發展，製造商專注於開發更有效率、更具創新性的傷口清洗解決方案，以提高癒合效果並改善患者照護。隨著創傷護理產品需求的不斷上升，預計未來幾年傷口清洗市場將大幅成長。

影響分析

傷口清洗市場受到以下因素的影響：

加強創傷護理實踐：先進傷口清洗劑的引入顯著改善了創傷護理實踐。這些清洗清洗傷口提供了更有效的解決方案，最大限度地降低了感染的風險並促進了癒合過程。
降低感染率：抗菌傷口清洗產品在降低醫療環境中的感染率方面發揮關鍵作用。這些產品可防止傷口中細菌和病原體的生長，從而減少併發症的機會。
加速癒合：傷口清洗配方的創新縮短了癒合時間。有效清除傷口碎片和死組織可以讓我們專注於修復傷口。
提高患者的舒適度：溫和而有效的傷口清洗產品的開發提高了患者在治療期間的舒適度。清洗過程中減少疼痛和刺激可提高對規定護理方案的依從性。
降低醫療成本：透過預防併發症和加速癒合，傷口清洗產品有助於降低醫療成本。較低的感染率和較短的住院時間意味著患者和醫療保健系統的經濟節省。
提高可近性：傷口清洗技術的進步使其能夠廣泛應用於各種醫療保健場所，包括醫院、診所和居家照護場所。這確保了患者無論身在何處都能得到優質的創傷護理。
最尖端科技的整合：傷口清洗市場正在融入新技術，例如可監測癒合進度和自動給藥的智慧傷口清洗。這些創新使得創傷護理策略更加個人化和有效。
持續的研究與發展：傷口清洗市場的持續成長導致研發投資的增加。這包括探索新的成分、配方和給藥方法，以持續改善患者的治療效果。

市售傷口清洗預計將主導創傷護理市場，其針對性配方旨在有效清洗傷口並創造最佳癒合環境。這些清洗有多種形式，可根據特定的創傷護理需求量身定做，通常含有活性成分，有助於去除碎屑、細菌和污染物，同時促進癒合過程。它在處理各種傷口方面的專業化和有效性使其成為醫療保健提供者和患者的首選，從而推動其在市場上持續佔據主導地位。

生理食鹽水清洗預計將以最快的速度成長，主要是因為它使用方便、安全、作用溫和。生理食鹽水是由純淨水的氯化鈉無菌溶液組成的，與人體的天然體液相似，是傷口沖洗和清洗的理想、溫和的選擇。生理食鹽水清洗廣泛應用於臨床和居家照護環境，由於其成本低、併發症風險低，成為創傷護理市場中成長迅速的一個領域。

慢性傷口是一種複雜的長期損傷，由於自然癒合過程受損而導致，通常是由於糖尿病等潛在疾病引起的。這些傷口，包括壓瘡、糖尿病足潰瘍和靜脈性腿部潰瘍，很難癒合，並且可能持續數月甚至數年。約 15-25% 的糖尿病患者有慢性傷口的風險。由於慢性傷口的持續性和慢性病的盛行率上升，預計慢性傷口將佔據傷口清洗劑市場的主導地位。對有效對抗感染疾病、促進癒合和控制併發症的專用創傷護理產品的需求正在推動該領域的持續需求。

急性傷口通常在四至六週內癒合，通常是創傷或損傷的結果。儘管這些傷口有不同的癒合軌跡，但其全球發生率呈上升趨勢，特別是在事故、手術和運動相關傷害更為普遍的已開發地區。隨著急性傷口病例數量的增加，對治療這些傷害的有效傷口清洗產品的需求可能會迅速成長。由於恢復時間短、數量大，以及人們對正確傷口管理以防止感染疾病等併發症的認知不斷提高，急性傷口護理領域預計將以最快的速度成長。

醫院部門在傷口清洗劑市場中處於領先地位，因為它在急性和慢性傷口的治療中佔有重要佔有率。醫院是需求的主要驅動力，因為它們有能力處理複雜的病例，例如外科性創傷、燒傷和創傷相關的損傷，所有這些病例都需要專門的傷口清洗解決方案。此外，醫院擁有先進的醫療資源，是創傷護理的重要中心。

居家照護領域是成長最快的市場。推動這一成長的因素是人們對家庭傷口管理的偏好日益成長，尤其是對於糖尿病潰瘍和壓瘡等慢性疾病。消費者自我護理意識的不斷提高以及先進的創傷護理產品的便利性和可用性正在推動傷口清洗市場中家庭護理領域的快速擴張。

預計北美將在 2024 年佔據最大的市場佔有率，這得益於其先進的醫療基礎設施、強大的經濟支持以及糖尿病和肥胖症等慢性疾病的患病率不斷上升，這些疾病導致慢性傷口的發病率不斷上升。在美國，傷口清洗的需求主要由 3M 等主要製造商推動，3M 提供 3M Tegaderm 傷口清潔劑等產品，而 Medline 則提供 Medline Remedy Phytoplex 皮膚和傷口清潔劑。這些產品廣泛應用於醫院和家庭護理環境，因為它們有助於預防感染並促進更快癒合。此外，北美人口老化正在推動創傷護理產品的需求，因為超過六百萬美國患有慢性傷口，特別是壓瘡和糖尿病足潰瘍。這種人口結構的變化，加上全面的醫療政策確保人們能夠更廣泛地獲得創傷護理產品，正在推動傷口清洗產品市場的成長。

2024 年，中國將引領亞太地區傷口清洗劑市場。這一成長的主要驅動力包括對傷口修復產品的需求不斷增加、慢性傷口盛行率不斷上升以及全部區域外科手術數量的增加。造成這項需求的一個顯著因素是華人糖尿病盛行率高，增加了對創傷護理解決方案的需求，以解決糖尿病患者癒合延遲的問題。足部潰瘍是糖尿病患者常見且嚴重的併發症，常導致截肢等嚴重後果。根據國際糖尿病聯盟（IDF）的數據，2021年華人糖尿病患者數量為1.409億，佔總人口的10.6%。預計到 2030 年，這一數字將上升至 1.6406 億，2021 年未確診病例估計將達到 7,283 萬人。糖尿病的高盛行率直接導致對糖尿病足部護理管理和創傷護理產品的需求增加，尤其是與糖尿病足部潰瘍相關的產品。

傷口清洗劑市場的最新趨勢

2023 年 4 月，Sanara MedTech Inc. 宣布其 Biasurge Advanced Surgical Solution 已獲得 510(k) 許可，這是一種利用 Biacos 技術的專有配方。 Biasurge 旨在機械清洗和清除傷口中的碎屑（包括微生物）。
2023 年 1 月，Sonoma Pharmaceuticals, Inc. 揭露已收到國防後勤局 (DLA) 就其 Microcyn Rx 產品簽訂的分銷和定價協議。該協議標誌著該公司的一個重要里程碑，因為它使得 Microcyn Rx 產品能夠透過 DLA 的網路分銷。
2021年11月，Sonoma Pharmaceuticals, Inc.與Dyamed Biotech Pte Ltd.擴大了長期夥伴關係關係，重點關注新加坡、馬來西亞、印尼和泰國市場。此次合作旨在利用 Sonoma 的 Microcyn 技術使患者和醫療保健提供者受益。
2021 年 3 月，Sonoma Pharmaceuticals, Inc. 與 EMC Pharma, LLC 達成協議，負責在美國監督、促銷和分銷 Sonoma 基於 HOCl 的處方皮膚病學和眼科產品。
2022 年 11 月，InfuSystem Holdings, Inc. 與 Sanara MedTech Inc.夥伴關係成立 SI Wound Care, LLC。此次夥伴關係將使 InfuSystem 能夠向新客戶推出創新產品，例如 Cork Medical LLC 的負壓傷口護理設備和 Sanara 的先進創傷護理解決方案。
2023 年 6 月，Armis Biopharma 的醫療設備VeriCyn Wound Wash 獲得 FDA 的 510(k) 許可，可用於清洗傷口沉積物。
2023年4月，康維泰克從英國30 Technology公司收購了一項技術，引發了人們對該技術將如何以及何時融入康維泰克現有產品系列的猜測。
2023 年 2 月，Shore Capital Partners 將 Argentum Medical 出售給 BioDerm。
2023年5月，NovaBay Pharmaceuticals, Inc.宣布，中國先鋒製藥控股有限公司已訂購NovaBay的NeutroPhase皮膚和傷口清潔劑，價值100萬美元。 NovaBay預計於2023年第二季完成訂單並確認相關收益。
2019年5月，全錄輝收購了Osiris Therapeutics, Inc.，該公司專注於開發和傳播用於傷口護理、整形外科和運動醫學的再生醫學產品。

市場需求促進因素：

慢性病盛行率上升推動傷口清洗劑的使用增加：全球慢性病的增加目前佔全球全球整體死亡人數的 63%，也是傷口感染疾病增加的主要原因。美國有超過1.33億人患有慢性病，佔總人口的40%以上。慢性病的激增直接影響了傷口清洗產品的需求，因此慢性傷口的管理對於改善患者的治療效果至關重要。

手術和創傷的激增將推動對傷口清洗產品的需求：由於醫療保健服務的改善和人口老化的快速發展，預計每年的手術數量將大幅增加。目前，全球每年進行約 3.13 億次外科手術，對有效傷口管理解決方案（包括傷口清洗產品）的需求也增加。需要術後護理的創傷相關傷口發生率的增加進一步推動了這種需求。

提高消費者對傷口清洗產品的認知和接受度：對個人健康和衛生的認知不斷提高以及消費者對創傷護理的教育不斷增加，正在推動對傷口清洗產品的需求。當消費者積極處理急性和慢性傷口時，他們正在尋找可靠的解決方案來幫助他們更快地癒合。隨著醫療保健資訊的普及，消費者擴大選擇家庭治療，包括使用傷口清洗產品，以加速康復並預防感染。

傷口感染的增加推動市場成長：傷口感染疾病對於醫療保健提供者和患者來說都是一個主要的安全問題，特別是如果傷口沒有及時處理。傷口護理最重要的初始步驟是有效清洗感染區域，這將加快癒合過程。隨著全球患者數量的增加以及燒燙傷相關傷口感染的增加，對傷口清洗產品的需求不斷擴大，以滿足急性和慢性傷口管理的需要。

專科傷口護理診所的擴張推動了對先進產品的需求專注於治療複雜和慢性傷口的專科傷口診所的興起正在推動對先進創傷護理產品的需求。這些診所為患有糖尿病潰瘍、壓瘡和其他慢性傷口等難以治癒的疾病的患者提供服務，需要專門的創傷護理解決方案。隨著這些診所的興起，針對此類患者群體的特定需求而客製化的高品質、先進的傷口清洗產品的需求也隨之增加。

市場限制

醫學教育和意識不足：醫療和福利服務提供者的財務負擔以及對患者生活品質（QoL）的影響凸顯了傷口造成的巨大負擔。據歐洲傷口管理協會稱，慢性傷口的管理很複雜，可能會對患者的治療結果產生負面影響，因此創傷護理專業人員具備必要的知識和專業技能至關重要。如果沒有適當的教育，臨床醫生和患者都將難以最佳化護理，從而導致成本增加和康復時間延長。

報銷政策不足：醫療保健系統缺乏全面的傷口清洗劑報銷政策，阻礙了患者獲得治療，增加了自付費用，並給醫療機構帶來了額外的負擔。這些限制不僅限制了供應商的選擇，也抑制了創傷護理產品和服務的創新。此外，報銷不足可能會限制獲得所需治療的機會，從而加劇現有的醫療保健差距，特別是對於弱勢群體而言。

市場機會

新興經濟體的市場擴張：傷口清洗產品需求的不斷成長為中國、印度、巴西、沙烏地阿拉伯和新加坡等新興市場創造了巨大的成長機會。由於人口成長、未滿足的需求和醫療保健投資增加等因素，這些地區具有巨大的潛力。醫療保健支出的增加，尤其是在中東地區，為傷口清洗產品製造商創造了有利條件。此外，這些市場的人均可支配收入預計將會增加，從而進一步推動傷口清洗劑市場的擴張。

產品/創新策略：全球傷口清洗劑市場大致按產品、傷口類型、最終用戶和地區等不同類別。這有助於讀者清楚地了解哪個部分佔有最大佔有率以及哪個部分在未來幾年可能會成長。

本報告研究了全球傷口清洗市場，並概述了市場趨勢、產品類型、傷口類型、最終用戶和國家/地區，以及參與市場的公司概況。

競爭基準化分析
競爭格局
- 各公司主要策略及發展
- 關鍵進展
- 企業市場占有率分析/公司地位分析
公司簡介
- 3M
- ACTO GmbH
- Argentum Medical, LLC
- B.Braun SE
- Bactiguard SE
- Coloplast Group
- Cardinal Health
- Hollister Incorporated
- Gentell, Inc.
- Medline Industries
- Molnlycke Health Care AB
- Schulke & Mayr GmbH
- Smith & Nephew
- Sonoma Pharmaceuticals, Inc.
- Sanara Medtech, Inc.
- Urgo Medical

簡介目錄圖表

Product Code: BHM0468SC

Market Introduction

The wound cleanser market is a rapidly growing sector within the healthcare industry, driven by increasing demand for effective wound care solutions. A wound cleanser is a specialized solution designed to clean and irrigate wounds, playing a crucial role in wound care management. The wound cleanser market includes a wide range of products formulated to remove debris, bacteria, and contaminants from wounds, ensuring optimal healing and infection prevention. These products are essential in preparing wounds for subsequent medical treatments, such as dressing applications, suturing, or other therapeutic interventions, making the wound cleanser market a vital component of modern healthcare.

Several factors are fueling the expansion of the wound cleanser market, including the rising prevalence of chronic diseases, which has led to an increased demand for wound care products. The growing number of surgical and trauma cases has further amplified the need for wound cleansing solutions, contributing to the overall growth of the wound cleanser market. Additionally, the increasing incidence of wound infections has underscored the importance of effective wound cleaning, thereby driving innovation and advancements in the wound cleanser market.

Another significant factor contributing to the expansion of the wound cleanser market is the increasing acceptance and adoption of advanced wound care products. The rise of specialized wound care clinics, along with advancements in medical technology, has led to greater awareness and utilization of wound cleansers in both clinical and homecare settings. The wound cleanser market continues to evolve, with manufacturers focusing on developing more efficient and innovative wound cleansing solutions that enhance healing outcomes and improve patient care. As demand for wound care products continues to rise, the wound cleanser market is poised for substantial growth in the coming years.

Impact Analysis

The wound cleanser market has made an impact in the following ways:

Enhanced Wound Care Practices: The introduction of advanced wound cleansers has significantly improved wound care practices. These cleansers offer more effective solutions for cleaning wounds, minimizing infection risks, and accelerating the healing process.
Reduced Infection Rates: Wound cleansers with antimicrobial properties have played a key role in lowering infection rates across healthcare settings. These products help prevent bacterial and pathogen growth in wounds, reducing the likelihood of complications.
Accelerated Healing: Innovations in wound cleanser formulations have led to faster healing times. By efficiently removing debris and necrotic tissue, these products enable the body to focus on wound repair more effectively.
Improved Patient Comfort: The development of gentle yet effective wound cleansers has enhanced patient comfort during treatment. Reduced pain and irritation during cleansing promote better adherence to prescribed care regimens.
Cost Savings in Healthcare: By preventing complications and speeding up healing, wound cleansers contribute to reduced healthcare costs. Lower infection rates and shorter hospital stays generate financial savings for both patients and healthcare systems.
Increased Accessibility: Advancements in wound cleanser technologies have expanded accessibility to a broader range of healthcare facilities, including hospitals, clinics, and home care environments. This ensures that patients receive high-quality wound care regardless of location.
Integration of Cutting-Edge Technologies: The wound cleanser market has incorporated new technologies, such as smart wound cleansers that monitor healing progress or provide automated dosing. These innovations enable more personalized and effective wound care strategies.
Ongoing Research and Development: The continued growth of the wound cleanser market has fostered increased investment in research and development. This includes the exploration of novel ingredients, formulations, and delivery methods to consistently enhance patient outcomes.

Market Segmentation:

Segmentation 1: by Product

Commercial Cleanser
Saline

Commercial Cleanser to Continue Dominating the Wound Cleanser Market (by Product)

Commercial wound cleansers are expected to dominate the wound care market due to their targeted formulations designed to effectively cleanse wounds and create an optimal healing environment. Available in various forms and tailored to meet specific wound care needs, these cleansers typically contain active ingredients that help remove debris, bacteria, and contaminants while promoting the healing process. Their specialized nature and effectiveness in managing different types of wounds make them a preferred choice for both healthcare providers and patients, driving their continued market dominance.

Saline wound cleansers are projected to grow at the fastest rate, primarily due to their simplicity, safety, and gentle action. Composed of a sterile solution of sodium chloride in purified water, saline closely mimics the body's natural fluids, making it an ideal, non-irritating option for wound irrigation and cleansing. Their widespread use in both clinical and homecare settings, combined with their low cost and minimal risk of complications, positions saline cleansers as a rapidly growing segment in the wound care market.

Segmentation 2: by Wound

Chronic Wound
Acute Wound

Chronic Wound to Register Maximum Growth Rate in the Market

Chronic wounds are complex, long-lasting injuries that result from disruptions in the natural healing process, often due to underlying conditions such as diabetes. These wounds, such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers, are difficult to heal and may persist for months or even years. Approximately 15-25% of individuals with diabetes are at risk of developing chronic wounds. Due to their persistent nature and the increasing prevalence of chronic conditions, chronic wounds are expected to dominate the wound cleanser market. The need for specialized wound care products that effectively address infection, promote healing, and manage complications will drive sustained demand in this segment.

Acute wounds, which heal predictably within 4-6 weeks, typically result from external trauma or injury. While these wounds follow a clear healing trajectory, the global incidence is on the rise, particularly in developed regions where accidents, surgeries, and sports-related injuries are common. As the number of acute wound cases increases, the demand for effective wound cleansers to manage these injuries will grow rapidly. The acute wound care segment is anticipated to grow at the fastest rate due to its short recovery time, high volume, and the growing awareness of proper wound management to prevent complications such as infections.

Segmentation 3: by End User

Hospitals
Specialty Clinics
Homecare

Hospitals to Dominate the Global Wound Cleanser Market (by End User)

The hospital segment leads the wound cleanser market due to its substantial share in the treatment of both acute and chronic wounds. Hospitals are key drivers of demand, given their capacity to manage complex cases, including surgical wounds, burns, and trauma-related injuries, all of which require specialized wound cleansing solutions. Additionally, hospitals are equipped with advanced medical resources, making them a critical focal point for wound care.

The homecare segment is the fastest-growing in the market. This growth is fueled by the increasing preference for at-home wound management, particularly for chronic conditions such as diabetic ulcers and pressure sores. Rising consumer awareness of self-care, combined with the convenience and availability of advanced over-the-counter wound care products, is driving the rapid expansion of the homecare segment in the wound cleanser market.

Segmentation 4: by Region

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Portugal
- Netherlands
- Ireland
- Belgium
- Switzerland
- Norway
- Denmark
- Sweden
- Finland
- Czech Republic
- Russian Federation
- Poland
- Austria
- Romania
- Slovakia
- Greece
- Turkey
- Ukraine
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Thailand
- Malaysia
- Rest-of-Asia-Pacific
Latin America
- Brazil
- Argentina
- Chile
- Colombia
- Rest-of-Latin America
Rest-of-the-World

North America held the largest market share in 2024 due to its advanced healthcare infrastructure, strong economic support, and rising prevalence of chronic conditions such as diabetes and obesity, which contribute to an increased incidence of chronic wounds. In the U.S., the demand for wound cleansers is bolstered by leading manufacturers such as 3M, which offers products such as the 3M Tegaderm Wound Cleanser, and Medline, with their Medline Remedy Phytoplex Skin & Wound Cleanser. These products are widely used in hospitals and homecare settings for their effectiveness in preventing infections and promoting faster healing. Additionally, the aging population in North America drives the need for wound care products, with over 6 million Americans suffering from chronic wounds, particularly pressure ulcers and diabetic foot ulcers. This demographic shift is supported by comprehensive healthcare policies that ensure broad access to wound care products, fostering growth in the wound cleanser market.

China led the Asia-Pacific wound cleanser market in 2024. Key drivers of this growth include the increasing demand for wound recovery products, a rising prevalence of chronic wounds, and a growing number of surgical procedures throughout the region. A notable factor contributing to this demand is the high prevalence of diabetes in China, which heightens the need for wound care solutions to address delayed healing in diabetic patients. Foot ulcers, a common and debilitating complication among diabetic individuals, often lead to serious outcomes such as leg amputation. According to the International Diabetes Federation (IDF), China had 140.9 million cases of diabetes in 2021, representing 10.6% of the population. This number is projected to rise to 164.06 million by 2030, with an estimated 72.83 million undiagnosed cases in 2021. The high incidence of diabetes directly correlates with increased demand for diabetic foot care management and wound care products, particularly in the context of diabetic foot ulcers.

Recent Developments in the Wound Cleanser Market

In April 2023, Sanara MedTech Inc. announced receiving 510(k) clearance for its Biasurge advanced surgical solution, a patented formulation utilizing Biakos technology. Biasurge is designed for mechanical cleansing and the removal of debris, including microorganisms, from wounds.
In January 2023, Sonoma Pharmaceuticals, Inc. revealed a distribution and pricing agreement for its Microcyn Rx products, granted by the Defense Logistics Agency (DLA). This agreement enables the distribution of Microcyn Rx products through the DLA's network, marking a key milestone for the company.
In November 2021, Sonoma Pharmaceuticals, Inc. and Dyamed Biotech Pte Ltd. expanded their long-term partnership, focusing on the Singapore, Malaysia, Indonesia, and Thailand markets. The collaboration aims to leverage Sonoma's Microcyn technology, benefiting both patients and healthcare providers.
In March 2021, Sonoma Pharmaceuticals, Inc. entered into an agreement with EMC Pharma, LLC, to oversee, promote, and distribute Sonoma's prescription dermatology and eye care products based on HOCl in the U.S. The agreement is set for an initial term of five years, with potential for extension.
In November 2022, InfuSystem Holdings, Inc. and Sanara MedTech Inc. formed a partnership for SI Wound Care, LLC, aimed at delivering a comprehensive wound care solution that enhances patient outcomes, reduces care costs, and boosts satisfaction for both patients and providers. The partnership enables InfuSystem to introduce innovative products, including Cork Medical LLC's negative pressure wound therapy devices and Sanara's advanced wound care solutions, to new customers.
In June 2023, Armis Biopharma's VeriCyn Wound Wash medical device received 510(k) clearance from the FDA, allowing it to be used for cleansing wounds of debris.
In April 2023, Convatec acquired technology from U.K.-based 30 Technology, sparking speculation about how and when this technology will be integrated into Convatec's existing product portfolio.
In February 2023, Shore Capital Partners sold Argentum Medical to BioDerm.
In May 2023, NovaBay Pharmaceuticals, Inc. announced that China Pioneer Pharma Holdings, Limited had placed a $1 million order for NovaBay's NeutroPhase Skin and Wound Cleanser. NovaBay completed the order fulfillment and expects to recognize the associated revenue in Q2 2023.
In May 2019, Smith & Nephew acquired Osiris Therapeutics, Inc., a company specializing in the development and promotion of regenerative medicine products for wound care, orthopedics, and sports medicine.

Demand - Drivers and Limitations

Market Demand Drivers:

Rising Prevalence of Chronic Diseases Driving Increased Utilization of Wound Cleansers: The global rise in chronic diseases, now responsible for 63% of all global deaths, has significantly contributed to the increase in wound infections. In the U.S., chronic conditions affect over 133 million individuals-accounting for over 40% of the population. This surge in chronic disease prevalence is directly influencing the demand for wound cleansers, as managing chronic wounds becomes critical in improving patient outcomes.

Surge in Surgical and Trauma Cases Amplifying Demand for Wound Cleansers: With improved healthcare accessibility and a rapidly aging population, the number of surgical procedures performed annually is expected to rise substantially. Currently, approximately 313 million surgeries are conducted globally each year, creating a parallel increase in the need for effective wound management solutions, including wound cleansers. This demand is further amplified by the higher incidence of trauma-related wounds requiring post-operative care.

Growing Consumer Awareness and Acceptance of Wound Cleanser Products: Heightened awareness of personal health and hygiene, coupled with increasing consumer education on wound care, is driving the demand for wound cleanser products. As individuals become more proactive in managing both acute and chronic wounds, they seek reliable solutions for faster healing. With greater access to healthcare information, consumers are increasingly opting for at-home treatments, including wound cleansers, to ensure quicker recovery and prevent infections.

Escalating Incidence of Wound Infections Fostering Market Growth: Wound infections remain a significant safety concern for both healthcare providers and patients, particularly when wounds are not promptly addressed. The initial and most critical step in wound care is the effective cleansing of infected areas, which accelerates the healing process. With the rise in global patient populations and a growing number of burn-related wound infections, the demand for wound cleansers continues to expand to meet the needs of both acute and chronic wound management.

Expansion of Specialty Wound Care Clinics Driving Demand for Advanced Products: The increasing prevalence of specialty wound care clinics, which focus on treating complex and chronic wounds, is fueling the demand for advanced wound care products. These clinics cater to patients with difficult-to-heal conditions such as diabetic ulcers, pressure ulcers, and other chronic wounds, necessitating specialized wound care solutions. As these clinics proliferate, the need for high-quality, advanced wound cleansers tailored to the specific needs of these patient populations grows.

Market Restraints:

Insufficient Medical Education and Awareness: The financial strain on health and social care providers, coupled with the impact on patient quality of life (QoL), highlights the significant burden posed by wounds. According to the European Wound Management Association, it is crucial that those involved in wound care possess the necessary knowledge and expertise, as managing chronic wounds is complex and can adversely affect patient outcomes. Without proper education, both clinicians and patients may struggle to optimize care, leading to increased costs and prolonged recovery periods.

Inadequate Reimbursement Policies: The absence of comprehensive reimbursement policies for wound cleansers within healthcare systems creates barriers to patient access, increases out-of-pocket expenses, and places additional strain on healthcare facilities. This limitation not only reduces provider options but also stifles innovation in wound care products and services. Furthermore, the lack of reimbursement can exacerbate existing healthcare disparities, particularly for underserved populations, by limiting access to necessary treatment.

Market Opportunities:

Market Expansion in Emerging Economies: The growing demand for wound cleansers offers substantial growth opportunities in emerging markets, including China, India, Brazil, Saudi Arabia, and Singapore. These regions present significant potential driven by factors such as population growth, unmet healthcare needs, and increasing healthcare investments. In particular, the rising healthcare expenditure in the Middle East creates favorable conditions for wound cleanser manufacturers. Additionally, the expected increase in per capita disposable income in these markets further propels the expansion of the wound cleanser market.

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: The global wound cleanser market has been extensively segmented based on various categories, such as products, wound types, end users, and regions. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

Detailed secondary research was performed to ensure maximum coverage of manufacturers/suppliers operational in a country.
Exact revenue information, up to a certain extent, was extracted for each company from secondary sources and databases. The revenues specific to the product/type/application were then estimated for each market player based on fact-based proxy indicators as well as primary inputs.
The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of wound cleanser products.
The market contribution of the wound cleanser product anticipated to be launched in the future has been calculated based on historical analysis. This analysis has been supported by proxy factors such as the innovation scale of the companies, the status of funding, collaborations, customer base, and patent scenario.
The scope of availability of wound cleanser products in a particular region has been assessed based on a comprehensive analysis of companies' prospects, the regional end-user perception, and other factors impacting the launch of wound cleanser products in that region.
The base year considered for the calculation of the market size is 2024. A historical year analysis has been done for the period FY2021-FY2023. The market size has been estimated for FY2024 and projected for the period FY2025-FY2035.
Revenues of the companies have been referenced from their annual reports for FY2021, FY2022, and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, product approval status, market collaborations, and operational history.
Regional distribution of the market revenue has been estimated based on the companies in each region and the adoption rate of wound cleanser products. All the numbers have been adjusted to a single digit after the decimal for better presentation in the report. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. The CAGR has been calculated for the period 2025-2035.
The market has been mapped based on the available wound cleanser products. All the key companies with significant offerings in this field have been considered and profiled in this report.
Market strategies and developments of key players have been considered for the calculation of the potential of the market in the forecast period.

Primary Research:

The primary sources involve industry experts in the wound cleanser market, including the market players offering wound cleanser products and end users. Resources such as COOs, vice presidents, product managers, directors, territory managers, and business development have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

Validation and triangulation of all the numbers and graphs
Validation of the report's segmentation and key qualitative findings for wound cleansers
Understanding the competitive landscape and business model
Current and proposed production values of a product by market players
Validation of the numbers of the different segments of the market in focus
Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

National Center for Biotechnology Information (NCBI), PubMed, Science Direct, American Heart Association (AHA), Mayo Clinic, International Diabetes Federation, World Health Organization (WHO)
Annual reports, SEC filings, and investor presentations of the leading market players
Company websites and detailed study of their portfolios
Gold standard magazines, journals, whitepapers, press releases, and news articles
Databases

The key data points taken from the secondary sources include:

Segmentation and percentage share estimates
company and country understanding, and data for market value estimation.
Key industry/market trends
Developments among top players
qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names in this market are:

ACTO GmbH
Urgo Medical
Argentum Medical, LLC
Schulke & Mayr
Gentell, Inc.
Hollister Incorporated
Smith & Nephew
Sonoma Pharmaceuticals, Inc
B. Braun S.E.
Molnlycke Health Care AB
Coloplast Corp
Medline Industries, LP
Cardinal Health, Inc.
Sanara Medtech, Inc.
Bactiguard AB

Executive Summary

Scope of Study

Research Methodology

1. Global Wound Cleanser Market Overview

1.1 Market Outlook
- 1.1.1 Definitions
- 1.1.2 Inclusion and Exclusion Criteria
- 1.1.3 Market Size, 2024-2035 ($Million)
1.2 Industry Outlook
- 1.2.1 Introduction
- 1.2.2 Market Overview and Ecosystem
- 1.2.3 Key Trends
- 1.2.4 Opportunity Assessment
- 1.2.5 Pricing Analysis
- 1.2.6 Supply Chain Analysis
1.3 Market Dynamics
- 1.3.1 Market Opportunities and Trends
- 1.3.2 Market Drivers
  - 1.3.2.1 Impact Analysis
- 1.3.3 Market Restraints
  - 1.3.3.1 Impact Analysis

2. Global Wound Cleanser Market (By Product), $Million, 2023-2035

2.1 Opportunity Assessment
2.2 Growth-Share Matrix
2.3 Commercial Cleanser
- 2.3.1 Commercial Cleanser Market (by End User)
- 2.3.2 Commercial Cleanser Market (by Format Type)
2.4 Saline
- 2.4.1 Saline Wound Cleanser Market (by End User)

3. Global Wound Cleanser Market (By Wound), $Million, 2023-2035

3.1 Opportunity Assessment
3.2 Growth-Share Matrix
3.3 Chronic Wound
3.4 Acute Wound

4. Global Wound Cleanser Market (By End User), $Million, 2023-2035

4.1 Opportunity Assessment
4.2 Growth-Share Matrix
4.3 Hospitals
4.4 Specialty Clinics
4.5 Home Healthcare

5. Global Wound Cleanser Market (By Region), $Million, 2023-2035

5.1 Market Overview
- 5.1.1 North America
- 5.1.2 Legal Framework and Regulatory Requirements
- 5.1.3 Key Findings and Opportunity Assessment
- 5.1.4 Market Dynamics
  - 5.1.4.1 Impact Analysis
- 5.1.5 Market Sizing and Forecast
  - 5.1.5.1 North America Wound Cleanser Market (by Product)
  - 5.1.5.2 North America Wound Cleanser Market (by Country)
  - 5.1.5.3 Market Dynamics and Market Size Forecast
    - 5.1.5.3.1 U.S.
    - 5.1.5.3.2 Canada
- 5.1.6 Europe
- 5.1.7 Legal Framework and Regulatory Requirements
- 5.1.8 Key Findings and Opportunity Assessment
- 5.1.9 Market Dynamics
  - 5.1.9.1 Impact Analysis
- 5.1.10 Market Sizing and Forecast
  - 5.1.10.1 Europe Wound Cleanser Market (by Product)
  - 5.1.10.2 Europe Wound Cleanser Market (by Country)
  - 5.1.10.3 Market Dynamics and Market Size Forecast
    - 5.1.10.3.1 U.K.
    - 5.1.10.3.2 Germany
    - 5.1.10.3.3 France
    - 5.1.10.3.4 Italy
    - 5.1.10.3.5 Spain
    - 5.1.10.3.6 Portugal
    - 5.1.10.3.7 Ireland
    - 5.1.10.3.8 Switzerland
    - 5.1.10.3.9 Norway
    - 5.1.10.3.10 Belgium
    - 5.1.10.3.11 Denmark
    - 5.1.10.3.12 Netherlands
    - 5.1.10.3.13 Sweden
    - 5.1.10.3.14 Finland
    - 5.1.10.3.15 Czech Republic
    - 5.1.10.3.16 Russian Federation
    - 5.1.10.3.17 Poland
    - 5.1.10.3.18 Austria
    - 5.1.10.3.19 Romania
    - 5.1.10.3.20 Slovakia
    - 5.1.10.3.21 Greece
    - 5.1.10.3.22 Turkey
    - 5.1.10.3.23 Ukraine
- 5.1.11 Asia Pacific
- 5.1.12 Legal Framework and Regulatory Requirements
- 5.1.13 Key Findings and Opportunity Assessment
- 5.1.14 Market Dynamics
  - 5.1.14.1 Impact Analysis
- 5.1.15 Market Sizing and Forecast
  - 5.1.15.1 Asia-Pacific Wound Cleanser Market (by Product)
  - 5.1.15.2 Asia-Pacific Wound Cleanser Market (by Country)
  - 5.1.15.3 Market Dynamics and Market Size Forecast
    - 5.1.15.3.1 Japan
    - 5.1.15.3.2 China
    - 5.1.15.3.3 India
    - 5.1.15.3.4 Australia
    - 5.1.15.3.5 Thailand
    - 5.1.15.3.6 Malaysia
    - 5.1.15.3.7 South Korea
    - 5.1.15.3.8 Rest-of-Asia Pacific
- 5.1.16 Latin America
- 5.1.17 Legal Framework and Regulatory Requirements
- 5.1.18 Key Findings and Opportunity Assessment
- 5.1.19 Market Dynamics
  - 5.1.19.1 Impact Analysis
- 5.1.20 Market Sizing and Forecast
  - 5.1.20.1 Latin America Wound Cleanser Market (by Product)
  - 5.1.20.2 Latin America Wound Cleanser Market (by Country)
  - 5.1.20.3 Market Dynamics and Market Size Forecast
    - 5.1.20.3.1 Brazil
    - 5.1.20.3.2 Argentina
    - 5.1.20.3.3 Chile
    - 5.1.20.3.4 Colombia
    - 5.1.20.3.5 Rest-of-Latin America
- 5.1.21 Rest-of-the-World
- 5.1.22 Key Findings and Opportunity Assessment
- 5.1.23 Market Dynamics
  - 5.1.23.1 Impact Analysis
- 5.1.24 Market Sizing and Forecast
  - 5.1.24.1 Rest-of-the-World Wound Cleanser Market (by Product)
5.2 Future Potential

6. Global Wound Cleanser Market- Competitive Benchmarking and Company Profiles

6.1 Competitive Benchmarking
6.2 Competitive Landscape
- 6.2.1 Key Strategies and Developments by Company
  - 6.2.1.1 Funding Activities
  - 6.2.1.2 Merger and Acquisition
  - 6.2.1.3 Regulatory Approvals
  - 6.2.1.4 Partnerships, Collaboration, and Business Expansion
- 6.2.2 Key Developments Analysis
- 6.2.3 Company Share Analysis/ Company Position Analysis
6.3 Company Profiles
- 6.3.1 3M
  - 6.3.1.1 Company Overview
  - 6.3.1.2 Product Portfolio
  - 6.3.1.3 Target Customers/End Users
  - 6.3.1.4 Analyst View
- 6.3.2 ACTO GmbH
  - 6.3.2.1 Company Overview
  - 6.3.2.2 Product Portfolio
  - 6.3.2.3 Target Customers/End Users
  - 6.3.2.4 Analyst View
- 6.3.3 Argentum Medical, LLC
  - 6.3.3.1 Company Overview
  - 6.3.3.2 Product Portfolio
  - 6.3.3.3 Target Customers/End Users
  - 6.3.3.4 Analyst View
- 6.3.4 B.Braun S.E.
  - 6.3.4.1 Company Overview
  - 6.3.4.2 Product Portfolio
  - 6.3.4.3 Target Customers/End Users
  - 6.3.4.4 Analyst View
- 6.3.5 Bactiguard S.E.
  - 6.3.5.1 Company Overview
  - 6.3.5.2 Product Portfolio
  - 6.3.5.3 Target Customers/End Users
  - 6.3.5.4 Analyst View
- 6.3.6 Coloplast Group
  - 6.3.6.1 Company Overview
  - 6.3.6.2 Product Portfolio
  - 6.3.6.3 Target Customers/End Users
  - 6.3.6.4 Analyst View
- 6.3.7 Cardinal Health
  - 6.3.7.1 Company Overview
  - 6.3.7.2 Product Portfolio
  - 6.3.7.3 Target Customers/End Users
  - 6.3.7.4 Analyst View
- 6.3.8 Hollister Incorporated
  - 6.3.8.1 Company Overview
  - 6.3.8.2 Product Portfolio
  - 6.3.8.3 Target Customers/End Users
  - 6.3.8.4 Analyst View
- 6.3.9 Gentell, Inc.
  - 6.3.9.1 Company Overview
  - 6.3.9.2 Product Portfolio
  - 6.3.9.3 Target Customers/End Users
  - 6.3.9.4 Analyst View
- 6.3.10 Medline Industries
  - 6.3.10.1 Company Overview
  - 6.3.10.2 Product Portfolio
  - 6.3.10.3 Target Customers/End Users
  - 6.3.10.4 Analyst View
- 6.3.11 Molnlycke Health Care AB
  - 6.3.11.1 Company Overview
  - 6.3.11.2 Product Portfolio
  - 6.3.11.3 Target Customers/End Users
  - 6.3.11.4 Analyst View
- 6.3.12 Schulke & Mayr GmbH
  - 6.3.12.1 Company Overview
  - 6.3.12.2 Product Portfolio
  - 6.3.12.3 Target Customers/End Users
  - 6.3.12.4 Analyst View
- 6.3.13 Smith & Nephew
  - 6.3.13.1 Company Overview
  - 6.3.13.2 Product Portfolio
  - 6.3.13.3 Target Customers/End Users
  - 6.3.13.4 Analyst View
- 6.3.14 Sonoma Pharmaceuticals, Inc.
  - 6.3.14.1 Company Overview
  - 6.3.14.2 Product Portfolio
  - 6.3.14.3 Target Customers/End Users
  - 6.3.14.4 Analyst View
- 6.3.15 Sanara Medtech, Inc.
  - 6.3.15.1 Company Overview
  - 6.3.15.2 Product Portfolio
  - 6.3.15.3 Target Customers/End Users
  - 6.3.15.4 Analyst View
- 6.3.16 Urgo Medical
  - 6.3.16.1 Company Overview
  - 6.3.16.2 Product Portfolio
  - 6.3.16.3 Target Customers/End Users
  - 6.3.16.4 Analyst View

簡介目錄圖表

List of Figures

Figure: Global Wound Cleanser Market, Dynamics Impact Analysis
Figure: Global Wound Cleanser Market Coverage
Figure: Global Wound Cleanser Market, Key Trends, Impact Analysis, 2023-2035
Figure: Global Wound Cleanser Market, Patent Analysis, January 2022-March 2025
Figure: Global Wound Cleanser Market, Competitive Landscape, January 2022-March 2025